Article info
PDFDoping in sport
The case for and against harm reduction approaches to drugs in sport
- Correspondence to Professor C L Fry, Centre for Cultural Diversity and Wellbeing, Victoria University, Footscray, VIC 8001, Australia; craig.fry{at}vu.edu.au
Citation
The case for and against harm reduction approaches to drugs in sport
Publication history
- Accepted April 3, 2017
- First published April 25, 2017.
Online issue publication
April 26, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015
- Addict to win? A different approach to doping
- Globalisation of anti-doping: the reverse side of the medal
- Ethics of a relaxed antidoping rule accompanied by harm-reduction measures
- Drug use in English professional football
- Would they dope? Revisiting the Goldman dilemma
- Why we should allow performance enhancing drugs in sport
- Challenges and threats to implementing the fight against doping in sport
- Beyond antidoping and harm minimisation: a stakeholder-corporate social responsibility approach to drug control for sport
- FIFA’s approach to doping in football